Skip to main content
Polycystic Ovary Syndrome Basic Science to Clinical Advances Across the Lifespan

Cardiovascular risk reduction in polycystic ovary syndrome

Publication ,  Chapter
Shams, P; Ahmed, I; Samad, Z
January 1, 2023

PCOS patients have a higher prevalence of traditional risk factors for cardiovascular disease (CVD), and insulin resistance significantly contributes to the pathogenesis of these risk factors. Although central obesity has been reported to potentiate atherosclerosis, PCOS patients have an elevated risk of CVD irrespective of body mass index. Additionally, the prevalence of the subclinical atherosclerotic CVD (ASCVD) is reportedly higher in PCOS patients compared with controls. Nevertheless, there are limited data on the direct association of PCOS with clinical ASCVD (myocardial infarction and stroke). Population-based studies are required to establish the direct association of PCOS with clinical CVD. Lifestyle modifications, including a healthy diet, physical activity, weight reduction, and smoking cessation, reduce the CVD risk in PCOS. All patients with PCOS should be regularly screened treated for ASCVD risk factors and encouraged to have a healthy lifestyle.

Duke Scholars

DOI

Publication Date

January 1, 2023

Start / End Page

136 / 140
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shams, P., Ahmed, I., & Samad, Z. (2023). Cardiovascular risk reduction in polycystic ovary syndrome. In Polycystic Ovary Syndrome Basic Science to Clinical Advances Across the Lifespan (pp. 136–140). https://doi.org/10.1016/B978-0-323-87932-3.00027-X
Shams, P., I. Ahmed, and Z. Samad. “Cardiovascular risk reduction in polycystic ovary syndrome.” In Polycystic Ovary Syndrome Basic Science to Clinical Advances Across the Lifespan, 136–40, 2023. https://doi.org/10.1016/B978-0-323-87932-3.00027-X.
Shams P, Ahmed I, Samad Z. Cardiovascular risk reduction in polycystic ovary syndrome. In: Polycystic Ovary Syndrome Basic Science to Clinical Advances Across the Lifespan. 2023. p. 136–40.
Shams, P., et al. “Cardiovascular risk reduction in polycystic ovary syndrome.” Polycystic Ovary Syndrome Basic Science to Clinical Advances Across the Lifespan, 2023, pp. 136–40. Scopus, doi:10.1016/B978-0-323-87932-3.00027-X.
Shams P, Ahmed I, Samad Z. Cardiovascular risk reduction in polycystic ovary syndrome. Polycystic Ovary Syndrome Basic Science to Clinical Advances Across the Lifespan. 2023. p. 136–140.

DOI

Publication Date

January 1, 2023

Start / End Page

136 / 140